FOSUN PHARMA - Shanghai Fosun Pharmaceutical (Group) Co., Ltd.’s progress announcement on providing guarantees for its holding subsidiaries
Shanghai Fosun Pharmaceutical (Group) Co., Ltd.
Shanghai Fosun Pharmaceutical (Group) Co., Ltd.*
(a joint stock limited company incorporated in the People's Republic of China)
(Stock code: 02196)
Overseas regulatory announcement
This announcement is made in accordance with Rule 13.10B of the Rules Governing the Listing of Securities on The Stock Exchange of Hong Kong Limited.
The "Announcement on Progress in Providing Guarantees for its Controlled Subsidiaries" published by Shanghai Fosun Pharmaceutical (Group) Co., Ltd. (the "Company") on the website of the Shanghai Stock Exchange is hereby set out for reference only.
By order of the board of directors
Shanghai Fosun Pharmaceutical (Group) Co., Ltd.
Chairman
Chen Yuqing
China, Shanghai
July 3, 2026
As of the date of this announcement, the company’s executive directors are Mr. Chen Yuqing, Ms. Guan Xiaohui, Mr. Wen Deyong, Mr. Wang Kexin and Mr. Liu Yi; the company’s non-executive directors are Mr. Chen Qiyu and Mr. Pan Donghui; the company’s independent non-executive directors are Mr. Yu Zishan, Mr. Wang Quandi, Mr. Chen Penghui and Mr. Yang Yucheng; and the company’s employee director is Ms. Yan Jia.
*For identification only
Securities Code: 600196 Securities Abbreviation: Fosun Pharma Announcement Number: Lin 2026-094
Shanghai Fosun Pharmaceutical (Group) Co., Ltd.
Announcement on the progress of providing guarantees for holding subsidiaries
The company's board of directors and all directors guarantee that the contents of this announcement do not contain any false records, misleading statements or major omissions, and assume legal responsibility for the authenticity, accuracy and completeness of its contents.
Important content reminder:
Guarantee objects and basic information
NameFosun Industrial
The amount of this guarantee is equivalent to 350 million euros
As of July 3, 2026,
Including this guarantee, this
Equivalent to approximately RMB 7,249.83 million, the actual guarantee provided by the guaranteed party 11 Group
Guaranteed balance
Is it within the pre-expected amount? Yes □No □Not applicable: _________ The guaranteed party 1 is the guarantor (the company). Is there a counter guarantee for this guarantee?
Capital subsidiary, not involved in counter-guarantee arrangement Name Fosun Health
The guarantee amount is RMB 100 million
As of July 3, 2026,
Including this guarantee, this
Equivalent to approximately RMB 2,113.66 million, the actual guarantee provided by the guaranteed party 22 Group
Guaranteed balance
Is it within the pre-expected amount? Yes □No □Not applicable: ________
Is there a counter-guarantee for this guarantee Yes □No □Not applicable: ________
NameNantong Jianjia
The guarantee amount is RMB 15 million as of July 3, 2026.
Including this guarantee, this
The guarantee amount of RMB 51.5 million was actually provided by the guaranteed party 33 Group.
Guaranteed balance
Is it within the pre-expected amount? Yes □No □Not applicable: ________
Is there a counter-guarantee for this guarantee Yes □No □Not applicable: ________ Name Nanjing Jianjia
The guarantee amount is RMB 20 million as of July 3, 2026.
Including this guarantee, this
The guaranteed amount of RMB 38.9 million was guaranteed by party 44. The actual guarantee provided by the Group was
Guaranteed balance
Is it within the pre-expected amount? Yes □No □Not applicable: ________
Is there a counter-guarantee for this guarantee Yes □No □Not applicable: ________ Name Shanghai Jianjia
The guarantee amount is RMB 20 million as of July 3, 2026.
Including this guarantee, this
The guarantee amount of RMB 61 million was actually provided by the guaranteed party 55 Group.
Guaranteed balance
Is it within the pre-expected amount? Yes □No □Not applicable: ________
Is there a counter-guarantee for this guarantee Yes □No □Not applicable: ________
Accumulated guarantee situation
The cumulative amount of external guarantees overdue is RMB 0 as of July 33, 2002, 2002-26, including this current guarantee.
Equivalent to RMB 23,757.8 million1
Within the period, the Group’s actual external guarantee amount
The amount of external guarantees accounted for December 31, 2025
48.74%
Proportion of the Group’s audited net assets
In this guarantee, some of the assets and liabilities of the guaranteed party
Risk warning
The rate exceeds 70%.
- Overview of Guarantee
(1) Basic information about this guarantee
On July 3, 2026, the holding subsidiary Fosun Industrial signed the "Facility Agreement" (i.e., the loan agreement) with the loan syndicate and the loan syndicate's agent bank HSBC. Fosun Industrial applied to the loan syndicate and subsequent new loan banks (if any) in accordance with the agreement for a syndicated loan with a term of no more than 5 years and a principal amount of no more than the equivalent of 350 million euros. On the same day, the Company and HSBC signed the "Guarantee Contract One", whereby the Company will provide a joint liability guarantee for the above-mentioned syndicated loan. The guarantee period is from July 3, 2026 to three years after the expiration of the agreed debt performance period.
On July 2, 2026, the controlled subsidiary Fosun Health signed a "Comprehensive Credit Contract" with Minsheng Bank, and Fosun Health applied to Minsheng Bank for a credit line of RMB 100 million. The credit period is from July 3, 2026 to July 2, 2027. On the same day, the Company and Minsheng Bank signed the "Guarantee Contract II", stipulating that the Company will provide joint liability guarantee for Fosun Health's debts under the above-mentioned credit line. The guarantee period is three years from the expiration of the agreed debt performance period.
The counter-guarantee measures for this guarantee include: (1) Fosun Health's shareholders Li Qi, Hengsheng Industrial, and Lin JJ respectively pledged the equity held by them in Fosun Health; (2) Fosun Health's indirect shareholders Ningbo Lixing and Ningbo Likun (both indirect shareholding platforms for employees to participate in the incentive plan) respectively pledged their respective partnership shares in Ningbo Liding 2; (3) Fosun Health pledged other receivables.
1 Among them, foreign currencies are converted according to the relevant RMB exchange rate central parity announced by the People's Bank of China on that day, the same below.
2 is the shareholding platform of Fosun Health Equity Incentive Plan.
On July 2, 2026, the holding subsidiary Nantong Jianjia signed a "Fixed Asset Loan Contract" with Nantong Rural Commercial Bank. Nantong Jianjia applied for a fixed asset loan of RMB 5 million from Nantong Rural Commercial Bank. The loan period is from May 11, 2026 to June 21, 2029. On the same day, the holding subsidiary Jianjia Medical (the controlling shareholder of Nantong Jianjia) signed the "Guarantee Contract III" with Nantong Rural Commercial Bank, stipulating that Jianjia Medical will provide joint liability guarantee for the above-mentioned loans, and the guarantee period is three years from the expiration of the agreed debt performance period.
On July 2, 2026, Jianjia Medical signed the "Guarantee Contract IV" with Nantong Rural Commercial Bank, stipulating that the principal amount signed by Jianjia Medical for its controlled subsidiary Nantong Jianjia with Nantong Rural Commercial Bank from June 15, 2026 to May 10, 2029 shall not exceed RMB 1,000. The maximum amount of joint liability guarantee for debts under the main financing contract (including but not limited to working capital loans, etc.) of RMB 10,000 is provided, and the guarantee period is from July 2, 2026 to three years after the expiration of the debt performance period under the main contract.
Nantong Jianjia's other shareholder, Nantong Kangjian, pledged its 30% equity stake in Nantong Jianjia and provided counter-guarantee for the aforementioned guarantees 3 to 4 based on its shareholding ratio in Nantong Jianjia.
On July 2, 2026, Nanjing Jianjia, a holding subsidiary, signed the "Maximum Credit Limit Contract" with Bank of Nanjing, and Nanjing Jianjia applied for a credit line of RMB 10 million from Bank of Nanjing. The credit period is from July 1, 2026 to June 30, 2027. On the same day, Jianjia Medical (the controlling shareholder of Nanjing Jianjia) signed "Guarantee Contract Five" with Bank of Nanjing, stipulating that Jianjia Medical will provide the maximum joint liability guarantee for Nanjing Jianjia's debts under the above credit line, and the guarantee period is three years from the expiration of the agreed debt performance period.
On July 2, 2026, its holding subsidiary Jianjia Rehabilitation issued a "Letter of Guarantee" to the Nanjing Branch of the Bank of Jiangsu, stipulating that the principal amount signed by Jianjia Rehabilitation for its holding subsidiary Nanjing Jianjia with the Nanjing Branch of the Bank of Jiangsu from June 2, 2026 to May 27, 2027 shall not exceed RMB 1,000. The maximum amount of joint liability guarantee is provided for debts under the main financing contract of RMB 10,000, and the guarantee period is from July 2, 2026 to three years after the expiration of the debt performance period under the main contract.
Nanjing Jianjia intends to pledge a security deposit equal to the principal amount of the guaranteed debt to provide counter-guarantee for the aforementioned guarantees 5 to 6.
On July 2, 2026, Jianjia Rehabilitation signed the "Guarantee Contract Six" with the Zhangjiang Branch of the Bank of Jiangsu, stipulating that the principal amount signed by Jianjia Rehabilitation and its controlled subsidiary Shanghai Jianjia with the Zhangjiang Branch of the Bank of Jiangsu from June 2, 2026 to May 27, 2027 shall not exceed RMB 1,000. The maximum amount of joint liability guarantee is provided for the debts under the main financing contract of RMB 10,000, and the guarantee period is from July 2, 2026 to three years after the expiration of the debt performance period under the main contract.
On July 2, 2026, Jianjia Rehabilitation and Shanghai Pudong Development Bank signed "Guarantee Contract VII", stipulating that Jianjia Rehabilitation and its controlled subsidiary Shanghai Jianjia will sign with Shanghai Pudong Development Bank from June 25, 2026 to December 31, 2029, with a principal amount not exceeding RMB 1,000. The maximum amount of joint liability guarantee is provided for the debts under the main financing contract of RMB 10,000. The guarantee period for each debt is three years from the expiration date of the agreed performance period of the debt.
Shanghai Pu Nian, the other shareholder of Shanghai Jianjia, will pledge its 10% equity stake in Shanghai Jianjia and provide counter-guarantee for the aforementioned guarantees 7 to 8 in proportion to its shareholding in Shanghai Jianjia.
(2) Internal decision-making procedures for fulfilled guarantee matters
The 25th meeting of the tenth session of the Board of Directors and the 2025 annual shareholders' meeting of the Company have respectively reviewed and approved the proposals on the renewal and new guarantee limit of the Group. For details, please refer to the relevant announcements issued by the Company on March 25, 2026, June 17, 2026 in China Securities Journal, Shanghai Securities News, Securities Times and the Shanghai Stock Exchange website (https://www.sse.com.cn).
This guarantee is within the above-mentioned amount approved by the shareholders' meeting and does not require additional approval by the board of directors or shareholders' meeting.
(3) Basic information on guarantee estimates
With the approval of the company's shareholders' meeting, from the time of approval by the 2025 annual shareholders' meeting (i.e. June 16, 2026) to the end of the 2026 annual shareholders' meeting or the time when any shareholders' meeting passes a resolution to revoke or change the authorization mentioned in this proposal, the group can renew and add new guarantee lines not exceeding the equivalent of RMB 35,000,000 (including but not limited to the company's provision of guarantees for its controlled subsidiaries3 and its controlled subsidiaries providing guarantees for other controlled subsidiaries); at the same time,
3 Refers to wholly-owned and non-wholly-owned holding subsidiaries/units (including holding subsidiaries/units with an asset-liability ratio of more than 70% (including the principal amount)), the same below. The shareholders' meeting authorizes the company's management and/or its authorized persons to determine and adjust specific guarantee matters and sign relevant legal documents based on actual operating needs within the above-mentioned approved guarantee amount.
As of July 3, 2026, the approved guarantee amount and its usage (including this guarantee) are as follows:
Unit: RMB 10,000
Approved Used Remaining Available Secured Parties
Guarantee amount 4 Guarantee amount 4
The asset-liability ratio is less than 70% (excluding the original number)
3,000,000 308,494 2,691,506 controlled subsidiaries
The asset-liability ratio is above 70% (including the principal amount)
500,000 3,500 496,500 Controlled subsidiaries
Total 3,500,000311,9943,188,006
- Basic information of the guaranteed party
(1) Fosun Industrial
Legal person
Type
□Other______________ (please specify)
NameFosun Industrial
Wholly owned subsidiary
Listed company □Holding subsidiary
Its shareholding status □shareholding companies
□Other______________ (please specify)
Major shareholders and shareholding ratio: The company holds 100% of its shares
Chairman of the Board Guan Xiaohui
Established on September 22, 2004
Place of registration: Hong Kong, China
Foreign investment, sales and consulting business scope of Chinese and Western medicines, diagnostic reagents, and medical equipment products
consulting services, and related import and export business.
Main financial indicators for 2025 and January to March 2026
(Audited) (Unaudited)
- According to the authorization of the shareholders' meeting and based on business development needs, if there is an unused balance in the guarantee line provided for a holding subsidiary with an asset-liability ratio of more than 70% (including the principal amount), the balance can be adjusted to provide guarantees for a holding subsidiary with an asset-liability ratio of less than 70% (exclusive of the principal amount). (Individual basis, prepared in accordance with Hong Kong Financial Reporting Standards)
Total liabilities 79,090 72,451 Unit: ten thousand US dollars
Net assets 134,867 143,265 Operating income 616 261
Net profit 6,185 3,324
(2) Fosun Health
Legal person
Type
□Other______________ (please specify)
Name Fosun Health
□Wholly owned subsidiary
Listed companies Holding subsidiaries
Its shareholding status □shareholding companies
□Other______________ (please specify)
The Company, Ningbo Liding, Panli Qi, Lin JJ, Foshan Chanxi City Investment, and Hang Seng are major shareholders
Industrial and Foshan Changaocheng Venture Capital hold 85.7951%, 5.2224%, and shareholding ratios respectively.
3.3335%, 2.4800%, 2.2331%, 0.4893%, 0.4466% equity legal representative Hu Hang
Unified social credit code 913101155665993901
Date of establishment: December 28, 2010
Place of registration: China (Shanghai) Pilot Free Trade Zone
Registered capital RMB 5,827,835,909
Company Type Other Limited Liability Company
General projects: engaged in technology development, technical consulting, technical services, and technology transfer in the field of health technology; engaged in the medical and health industry and related fields (medical business scope
health care industry, medical education industry); accept entrustment by medical and health institutions to engage in hospital management and provide hospital management consulting (except brokerage).
2025 Project from January to March 2026
(Audited) (Unaudited)
Total assets 881,144 880,794Main financial indicators
(Individual caliber) Total liabilities 376,904 382,080 Unit: RMB 10,000
Net assets 504,240 498,714 Operating income 14,393 1,843
Net profit 3,990 -5,569
(3) Nantong Jianjia
Legal person
Type
□Other______________ (please specify)
NameNantong Jianjia
□Wholly owned subsidiary
Listed companies Holding subsidiaries
Its shareholding status □shareholding companies
□Other______________ (please specify)
Major shareholders and shareholding ratios: Jianjia Rehabilitation and Nantong Kangjian hold 70% and 30% of its equity respectively.
Legal representative Qiu Bin
Unified social credit code 91320602MADRTTKD61
Date of establishment: July 18, 2024
Place of registration: Nantong City, Jiangsu Province
Registered capital RMB 56 million
Company Type Limited Liability Company
Licensed items: medical services; catering services; food sales; third-category medical device operations (items that require approval according to law can only be carried out after approval by relevant departments, and specific business items are subject to the approval results) General items: Hospital business scope
Management; traditional Chinese medicine health care services (non-medical); sales of Class I medical devices; parking lot services; corporate management consulting; elderly care services; remote health management services; health consulting services (excluding diagnosis and treatment services); sales of Class II medical devices. 2025 Project from January to March 2026
(unaudited)(unaudited)
Total assets 16,807 16,743Main financial indicators
(Individual caliber) Total liabilities 13,181 13,275 Unit: RMB 10,000
Net assets 3,626 3,468 Operating income 94 309
Net profit -1,146 -441
(4) Nanjing Jianjia
Legal person
Type
□Other______________ (please specify) name Nanjing Jianjia
□Wholly owned subsidiary
Listed companies Holding subsidiaries
Its shareholding status □shareholding companies
□Other______________ (please specify) The main shareholders Jianjia Rehabilitation and Jiangsu Xiang'eqing Food Trading Co., Ltd. hold 99.50% and 0.50% of its shares respectively.
Legal representative Chen Haipeng
Unified social credit code 91320106302746668P
Established on February 13, 2015
Place of registration: Nanjing City, Jiangsu Province
Registered capital RMB 12.5 million
Company Type Limited Liability Company
Internal medicine, surgery, rehabilitation medicine (bone and joint rehabilitation, neurological rehabilitation, children's rehabilitation), medical laboratory; clinical chemistry laboratory specialty; medical imaging department; X business scope
Line diagnosis major, ultrasonic diagnosis major, electrocardiogram diagnosis major; traditional Chinese medicine department; parking lot management service; enterprise management consulting service.
2025 Project from January to March 2026
(Audited) (Unaudited)
Total assets 17,936 18,351Main financial indicators
Total liabilities 11,060 11,488 (single entity)
Unit: RMB 10,000
Net assets 6,876 6,863Operating income 11,444 1,744
Net profit 970 63
(5) Shanghai Jianjia
Legal person
Type
□Other______________ (please specify) name Shanghai Jianjia
□Wholly owned subsidiary
Listed companies Holding subsidiaries
Its shareholding status □shareholding companies
□Other______________ (please specify)
Major shareholders
Jianjia Rehabilitation and Shanghai Pu Nian hold 90% and 10% of its shares respectively.
and shareholding ratio
Legal representative Chen Haipeng
Unified social credit code 91310106MADHRYMD2C
Date of establishment: April 17, 2024
Place of registration: Shanghai
Registered capital RMB 60 million
Company Type Limited Liability Company
General projects: hospital management; conference and exhibition services (exhibitions abroad must be approved by relevant departments); cosmetics retail; cosmetics wholesale; daily necessities sales; first-class medical device sales; second-class medical device sales; professional cleaning, cleaning and disinfection services; parking lot services; property management; smart robot sales; smart home consumption Sales of free equipment; sales of wearable smart devices; sales of electronic products; sales of business scope health food (prepackaged); sales of formula foods for special medical purposes; sales of needle textiles; sales of office supplies; sales of household appliances; sales of sanitary products and disposable medical supplies; Internet sales (except for the sale of goods that require licensing). (Except for projects that require approval according to law, business activities can be carried out independently with a business license in accordance with the law) Licensed projects: medical services; catering services; food sales; third-class medical device operations.
2025 Project from January to March 2026
(Audited) (Unaudited)
Total assets 25,996 25,979Main financial indicators
(Individual caliber) Total liabilities 23,290 24,170 Unit: RMB 10,000
Net assets 2,706 1,810Operating income 196 379
Net profit -2,431 -903
- Main contents of the guarantee document
(1) "Guarantee Contract 1"
The Company shall provide joint liability guarantee for the syndicated loan with an equivalent value of no more than 350 million euros applied by Fosun Industrial to the loan syndicate and the subsequent new loan banks according to the contract (if any).
Guarantee scope: The debt principal, interest and other payable expenses that Fosun Industrial shall repay/pay to the loan syndicate according to the contract.
Guarantee period: from July 3, 2026 to three years after the expiration of the agreed debt performance period.
Effectiveness: "Guarantee Contract One" will take effect from July 3, 2026.
(2) "Guarantee Contract II"
The Company will provide a joint liability guarantee for the debts under the credit line of RMB 100 million applied by Fosun Health to Minsheng Bank.
Guarantee scope: The debt principal, interest and other payable expenses that Fosun Health shall repay/pay to Minsheng Bank according to the contract.
Guarantee period: three years from the expiration of the agreed debt performance period (including expiration in accordance with the contract or early expiration).
Effectiveness: "Guarantee Contract II" will take effect from July 2, 2026.
(3) "Guarantee Contract Three"
Jianjia Medical provides a joint liability guarantee for the fixed asset loan of RMB 5 million applied by Nantong Jianjia from Nantong Rural Commercial Bank.
Guarantee scope: The debt principal, interest and other payable expenses that Nantong Jianjia should repay/pay to Nantong Rural Commercial Bank according to the agreement.
Guarantee period: three years from the expiration of the agreed debt performance period; if it is agreed to be paid off in installments, the guarantee period is three years from July 2, 2026 to the expiration of the last debt performance period. 4. Effectiveness: "Guarantee Contract III" will take effect from July 2, 2026.
(4) "Guarantee Contract IV"
Jianjia Medical will provide the maximum joint liability guarantee for the debts (including but not limited to working capital loans, etc.) under the main financing contract with a principal of no more than RMB 10 million signed between Nantong Jianjia and Nantong Rural Commercial Bank from June 15, 2026 to May 10, 2029.
Guarantee scope: The debt principal, interest and other payable expenses that Nantong Jianjia should repay/pay to Nantong Rural Commercial Bank according to the agreement.
Guarantee period: from July 2, 2026 to three years after the expiration of the debt performance period under the main contract (including expiration in accordance with the contract, early expiration or extension).
Effectiveness: "Guarantee Contract IV" will take effect from July 2, 2026.
(5) "Guarantee Contract Five"
Jianjia Medical provides the maximum joint liability guarantee for the debt under the credit line of RMB 10 million applied by Nanjing Jianjia from the Bank of Nanjing.
Guarantee scope: The debt principal, interest and other payable expenses that Nanjing Jianjia should repay/pay to Nanjing Bank according to the agreement.
Guarantee period: Three years from the expiration of the agreed debt performance period (including expiration according to the contract, early expiration or extension).
Effectiveness: "Guarantee Contract Five" will take effect from July 2, 2026.
(6) "Letter of Guarantee"
Jianjia Rehabilitation will provide the maximum joint liability guarantee for the debts under the main financing contract with a principal of no more than RMB 10 million signed between Nanjing Jianjia and Bank of Jiangsu Nanjing Branch from June 2, 2026 to May 27, 2027.
Guarantee scope: The debt principal, interest and other payable expenses that Nanjing Jianjia shall repay/pay to Nanjing Branch of Bank of Jiangsu according to the agreement.
Guarantee period: from July 2, 2026 to three years after the expiration of the debt performance period under the main contract (including contractual maturity, early maturity or extension); if it is agreed to pay off the debt in installments, the guarantee period is from July 2, 2026 to three years after the expiration of the last debt performance period.
Effectiveness: The "Letter of Guarantee" will take effect from July 2, 2026.
(7) "Guarantee Contract Six"
Jianjia Rehabilitation will provide the maximum joint liability guarantee for the debts under the main financing contract with a principal of no more than RMB 10 million signed between Shanghai Jianjia and Jiangsu Bank Zhangjiang Branch from June 2, 2026 to May 27, 2027.
Guarantee scope: The debt principal, interest and other payable expenses that Shanghai Jianjia shall repay/pay to Jiangsu Bank Zhangjiang Branch according to the agreement.
Guarantee period: from July 2, 2026 to three years after the expiration of the debt performance period under the main contract (including contractual maturity, early maturity or extension); if it is agreed to pay off the debt in installments, the guarantee period is from July 2, 2026 to three years after the expiration of the last debt performance period.
Effectiveness: "Guarantee Contract VI" will take effect from July 2, 2026.
(8) "Guarantee Contract Seven"
Jianjia Rehabilitation will provide the maximum joint liability guarantee for the debts under the main financing contract with a principal of no more than RMB 10 million signed between Shanghai Jianjia and Shanghai Pudong Development Bank from June 25, 2026 to December 31, 2029.
Guarantee scope: The debt principal, interest and other payable expenses that Shanghai Jianjia shall repay/pay to Shanghai Pudong Development Bank according to the agreement.
Guarantee period: It should be calculated separately for each debt, that is, three years from the expiration date of the agreed performance period of the debt (including contractual maturity, early maturity or extension); if it is agreed to pay off the debt in installments, the guarantee period is from the expiration date of each debt period to three years from the expiration date of the last debt period.
Effectiveness: "Guarantee Contract VII" will take effect from July 2, 2026.
4. Necessity and Reasonability of Guarantee
This guarantee is a guarantee between the company and its holding subsidiaries, and its holding subsidiaries. The financing involved in the guarantee is to meet the actual operating needs of the relevant holding subsidiaries. The risks of this guarantee are relatively controllable, necessary and reasonable, and there will be no harm to the interests of the company and its shareholders.
- Opinions of the Board of Directors
This guarantee occurred within the group's renewal and new guarantee limit approved by the company's 2025 shareholders' meeting. When reviewing the limit, the board of directors believed that since the guaranteed party was limited to the company's controlled subsidiaries, the guarantee matters under the limit occurred due to the operating needs of the group, and the guarantee risks were relatively controllable. Therefore, the board of directors agreed with the guarantee limit matter and agreed to submit it to the shareholders' meeting for review. When the board of directors voted on the matter, all directors (including independent non-executive directors) unanimously agreed.
According to the authorization of the company's 2025 annual shareholders' meeting, this guarantee does not require separate approval by the board of directors.
- Cumulative number of external guarantees and number of overdue guarantees
As of July 3, 2026, including this guarantee, the Group's actual external guarantee amount is equivalent to approximately RMB 23,757.8 million, accounting for approximately 48.74% of the Group's audited net assets attributable to shareholders of listed companies as of December 31, 2025; all are guarantees between the Company and its holding subsidiaries/units, and between its holding subsidiaries/units.
As of July 3, 2026, the Group had no overdue guarantees.
- Interpretation
Secured party 1.
Refers to Fosun Industrial (Hong Kong) Co., Ltd.
Fosun Industrial
Secured party 2.
Refers to Shanghai Fosun Health Technology (Group) Co., Ltd. Fosun Health
Secured party 3.
Guide Tong Jianjia Rehabilitation Hospital Co., Ltd.
Nantong Jianjia
Secured party 4.
Guide to Jingjianjia Rehabilitation Hospital Co., Ltd.
Nanjing Jianjia
Secured party 5.
Refers to Shanghai Jianjia Rehabilitation Hospital Co., Ltd.
Shanghai Jianjia
This company refers to Shanghai Fosun Pharmaceutical (Group) Co., Ltd.
The group refers to the company and its holding subsidiaries/units
(1) Mashreqbank P.S.C., Hong Kong Branch, (2) Natixis, Hong Kong Branch, (3) HSBC Bank, (4) Qatar National Bank (Q.P.S.C.), Hong Kong Branch, (5) Banco Bilbao Vizcaya Argentaria, S.A., Hong Kong Branch, (6) Loan syndicate refers to Nanyang Commercial Bank, Limited, (7) The Korea Development Bank Hong Kong Branch, (8) KDB Asia Limited, (9) Standard Chartered Bank (Hong Kong) Limited, (10) The Bank of East Asia Limited, (11) Chiyu Banking Corporation Limited, and (12) Hang Seng Bank Limited
Foshan Chanxi City Investment refers to Foshan Chancheng District Chanxi New City Investment and Construction Co., Ltd.
Foshan Changaocheng Venture Capital refers to Foshan Changaocheng Venture Capital Fund Partnership (Limited Partnership) Hengsheng Industrial refers to Shenzhen Hengsheng Industrial Group Co., Ltd.
Jianjia Rehabilitation refers to Shanghai Jianjia Rehabilitation Technology Co., Ltd.
Jianjia Medical refers to Jianjia Medical Investment Management Co., Ltd.
Bank of Jiangsu Nanjing Branch refers to Bank of Jiangsu Co., Ltd. Nanjing Branch
Bank of Jiangsu Zhangjiang Branch refers to Shanghai Zhangjiang Branch of Bank of Jiangsu Co., Ltd.
The Hongkong and Shanghai Banking
Corporation Limited
Minsheng Bank refers to China Minsheng Banking Co., Ltd. Shanghai Branch
Bank of Nanjing Bank of Nanjing Co., Ltd. Nanjing Chengbei Branch
Nantong Health Guide Tong Health Investment Partnership (Limited Partnership)
Nantong Rural Commercial Bank refers to Jiangsu Nantong Rural Commercial Bank Co., Ltd.
Ningbo Liding Designated Ningbo Liding Enterprise Management Partnership (Limited Partnership)
Ningbo Meishan Bonded Port Area Likun Enterprise Management Partnership (Ningbo Likun Limited)
partnership)
Ningbo Meishan Bonded Port Area Lixing Enterprise Management Partnership (Limited Ningbo Lixing Index
partnership)
Shanghai Pudong Development Bank refers to Changning Branch of Shanghai Pudong Development Bank Co., Ltd.
Shanghai Pu Nian refers to Shanghai Pu Nian Medical Management Center (Limited Partnership)
On July 3, 2026, the "Guarantee Contract One" signed by the Company and HSBC Bank refers to
《Guarantee》
On July 2, 2026, the company signed the "Guarantee Contract II" with Minsheng Bank Shanghai Branch.
"Maximum Guarantee Contract" signed
On July 2, 2026, the "Guarantee Contract Three" signed between Jianjia Medical and Nantong Rural Commercial Bank refers to
"Guarantee Contract"
On July 2, 2026, the "Guarantee Contract IV" signed between Jianjia Medical and Nantong Rural Commercial Bank refers to
"Maximum Guaranteed Contract"
On July 2, 2026, the "Guarantee Contract Five" signed between Jianjia Medical and Bank of Nanjing refers to
High Guaranteed Contract》
Refers to the "Guarantee Contract Six" between Jianjia Rehabilitation and Jiangsu Bank Zhangjiang Branch on July 2, 2026
"Maximum Guarantee Contract" signed
Refers to the "Guarantee Contract Seven" signed between Jianjia Rehabilitation and Shanghai Pudong Development Bank on July 2, 2026
High Guaranteed Contract》
Refers to the "Letter of Guarantee" issued by Jianjia Rehabilitation to Nanjing Branch of Bank of Jiangsu on July 2, 2026.
"Maximum Joint and Several Liability Guarantee" issued
Announcement is hereby made.
Board of Directors of Shanghai Fosun Pharmaceutical (Group) Co., Ltd.
July 3, 2026